Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM. Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 1987;2(8574):1486–8.
Furukawa K, Matsuta K, Takeuchi F, Kosuge E, Miyamoto T, Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int Immunol 1990;2(1):105–12.
Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, et al. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest 1992;89(3):1021–31.
Wilson IB, Platt FM, Isenberg DA, Rademacher TW. Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis. J Rheumatol 1993;20(8):1282–7.
Alavi A, Axford J. Evaluation of beta 1,4-galactosyltransferase in rheumatoid arthritis and its role in the glycosylation network associated with this disease. Glycoconj J 1995;12(3):206–10.
Keusch J, Lydyard PM, Berger EG, Delves PJ. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconj J 1998;15(11):1093–7.
Alavi A, Axford JS, Hay FC, Jones MG. Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis. Ann Med Interne (Paris) 1998;149(5):251–60.
Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A 1994;91(13):6123–7.
Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, et al. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 1991;34(11):1425–9.
Alavi A, Arden N, Spector TD, Axford JS. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 2000;27(6):1379–85.
Kuroda Y, Nakata M, Hirose S, Shirai T, Iwamoto M, Izui S, et al. Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis. Pathol Int 2001;51(12):909–15.
Keusch J, Lydyard PM, Delves PJ. The effect on IgG glycosylation of altering beta1, 4-galactosyltransferase-1 activity in B cells. Glycobiology 1998;8(12):1215–20.
Lo NW, Shaper JH, Pevsner J, Shaper NL. The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 1998;8(5):517–26.
Guo S, Sato T, Shirane K, Furukawa K. Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 2001;11(10):813–20.
Amado M, Almeida R, Schwientek T, Clausen H. Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1999;1473(1):35–53.
Kido M, Asano M, Iwakura Y, Ichinose M, Miki K, Furukawa K. Normal levels of serum glycoproteins maintained in beta-1, 4-galactosyltransferase I-knockout mice. FEBS Lett 1999;464(1–2):75–9.
Kotani N, Asano M, Iwakura Y, Takasaki S. Knockout of mouse beta 1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. Biochem J 2001;357(Pt 3):827–34.
Kotani N, Asano M, Iwakura Y, Takasaki S. Impaired galactosylation of core 2 O-glycans in erythrocytes of beta1,4-galactosyltransferase knockout mice. Biochem Biophys Res Commun 1999;260(1):94–8.
Jeddi PA, Bodman-Smith KB, Lund T, Lydyard PM, Mengle-Gaw L, Isenberg DA, et al. Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse. Immunology 1996;87(4):654–9.
Jefferis R, Lund J. Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett 2002;82(1–2):57–65.
Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1(3):237–43.
Soltys AJ, Hay FC, Bond A, Axford JS, Jones MG, Randen I, et al. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994;40(2):135–43.
Bond A, Kerr MA, Hay FC. Distinct oligosaccharide content of rheumatoid arthritis-derived immune complexes. Arthritis Rheum 1995;38(6):744–9.
Isenberg DA, Lydyard PM, Axford JS, Hay FC, Rook GW, Roitt IM, et al. Galactosylation of IgG associated oligosaccharides. Lancet 1988;2(8605):288.
van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, Ghelani S, et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol 1994;33(1):36–43.
Axford J, Gunnane G, FitzGerald O, Martin Bland J, Bresnihan B, Frears ER. Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis. J Rheumatol 2003; 30(12):2540–6.
Alavi A. The Glycosyltransferases. In Abnormalities of IgG glycosylation and immunological disorders. 1996:149–169.
Kleene R, Berger EG. The molecular and cell biology of glycosyltransferases. Biochim Biophys Acta 1993;1154(3–4):283–325.
Shur BD, Evans S, Lu Q. Cell surface galactosyltransferase: current issues. Glycoconj J 1998;15(6):537–48.
Davey RA, Harvie RM, Cahill EJ, Levi JA. Serum galactosyltransferase isoenzymes as markers for solid tumours in humans. Eur J Cancer Clin Oncol 1984;20(1):75–9.
Strous GJ. Golgi and secreted galactosyltransferase. CRC Crit Rev Biochem 1986;21(2):119–51.
Dinter A, Berger EG. The regulation of cell-and tissue-specific expression of glycans by glycosyltransferases. Adv Exp Med Biol 1995;376:53–82.
Zhang SW, Xu SL, Cai MM, Yan J, Zhu XY, Hu Y, et al. Effect of p58GTA on beta-1,4-galactosyltransferase 1 activity and cell-cycle in human hepatocarcinoma cells. Mol Cell Biochem 2001;221(1–2):161–8.
Delves PJ, Lund T, Axford JS, Alavi-Sadrieh A, Lydyard PM, MacKenzie L, et al. Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients. Arthritis Rheum 1990;33(11):1655–64.
Furukawa K, Roth S. Embryonic and adult forms of two galactosyltransferases differ in their degrees of sialylation. Eur J Biochem 1985;150(1):175–80.
Gerber AC, Kozdrowski I, Wyss SR, Berger EG. The charge heterogeneity of soluble human galactosyltransferases isolated from milk, amniotic fluid and malignant ascites. Eur J Biochem 1979;93(3):453–60.
Davey R, Bowen R, Cahill J. The analysis of soluble galactosyltransferase isoenzyme patterns using high resolution agarose isoelectricfocusing. Biochem Int 1983;6(5):643–51.
Davey R, Harvie R, Cahill J, Levi J. Serum galactosyltransferase isoenzyme patterns of cancer patients with liver involvement. Br J Cancer 1986;53(2):211–5.
Uemura M, Sakaguchi T, Uejima T, Nozawa S, Narimatsu H. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids. Cancer Res 1992;52(22):6153–7.
Endo T, Amano J, Berger EG, Kobata A. Structure identification of the complex-type, asparaginelinked sugar chains of beta-D-galactosyl-transferase purified from human milk. Carbohydr Res 1986;150:241–63.
Amano J, Straehl P, Berger EG, Kochibe N, Kobata A. Structures of mucin-type sugar chains of the galactosyltransferase purified from human milk. Occurrence of the ABO and Lewis blood group determinants. J Biol Chem 1991;266(18):11461–77.
Malissard M, Berger EG. Improving solubility of catalytic domain of human beta-1,4-galactosyltransferase 1 through rationally designed amino acid replacements. Eur J Biochem 2001;268(15):4352–8.
Soltys A, Alavi A, Dalziel M, Axford J. Galactosyltransferase isoenzymes in rheumatoid arthritis and healthy individuals [abstract]. Glycosylation & Disease 1994;1:204.
Alavi A, Axford JS, Pool A. Serum galactosyltransferase isoform changes in rheumatoid arthritis. J Rheumatol. 2004; 31(8):1513–20.
Qian GX, Liu CK, Waxman S. Abnormal isoelectric focusing patterns of serum galactosyltransferase activity in patients with liver neoplasia. Proc Soc Exp Biol Med 1984;175(1):21–4.
Kessel D, Allen J. Elevated plasma sialyltransferase in the cancer patient. Cancer Res 1975;35(3):670–2.
Basset C, Durand V, Mimassi N, Pennec YL, Youinou P, Dueymes M. Enhanced sialyltransferase activity in B lymphocytes from patients with primary Sjogren’s syndrome. Scand J Immunol 2000;51(3):307–11.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this paper
Cite this paper
Alavi, A., Pool, A.J., Axford, J.S. (2005). New Insights into Rheumatoid Arthritis Associated Glycosylation Changes. In: Axford, J.S. (eds) Glycobiology and Medicine. Advances in Experimental Medicine and Biology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25515-X_23
Download citation
DOI: https://doi.org/10.1007/0-387-25515-X_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25514-9
Online ISBN: 978-0-387-25515-6
eBook Packages: MedicineMedicine (R0)